文献速递心脏核医学

心肌灌注显像在糖尿病中的应用:证据要点与待解答临床问题

Myocardial perfusion imaging for diabetes: Key points from the evidence and clinical questions to be answered.
PubMed 文献 · J Nucl Cardiol · 2019-08-13

本文综述了心肌灌注显像(MPI)在糖尿病合并疑似或已知冠心病患者诊断与风险评估中的作用。糖尿病心血管病变涉及大血管和微血管的多因素病理过程,SPECT和PET MPI使用不同示踪剂可评估心肌血流、左室功能及大/微血管损伤的生理后果。

要点

  • MPI可区分正常与病变心肌组织并评估左室功能。
  • MPI可监测心肌血流,反映糖尿病大/微血管损伤的生理后果。
  • MPI用于糖尿病合并疑似或已知CAD的诊断与风险评估。

核心结论

  • MPI是评估糖尿病患者大血管和微血管损伤生理后果的重要工具。

研究设计与样本

  • 综述,总结MPI在糖尿病合并疑似或已知CAD患者诊断与风险评估中的证据。

主要发现

  • 糖尿病心血管病变涉及大血管和微血管的多因素病理过程。
  • SPECT和PET MPI使用不同示踪剂可评估心肌血流和左室功能。

临床怎么用

  • 对糖尿病合并疑似或已知CAD患者,可考虑应用MPI进行诊断和风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetes represents a worldwide increasing problem and cardiovascular disease is the most common cause of death in diabetic patients. Pathophysiology that links diabetes to cardiovascular disease is a complex and multifactorial phenomenon evolving over time and involving both large blood vessels (macrovasculature) and small blood vessels (microvasculature). Myocardial perfusion imaging (MPI) imaging by both single-photon emission computer tomography and positron emission tomography with different specific tracers has become an indispensable tool for discriminating normal from diseased myocardial tissues and left ventricular function and monitoring myocardial blood flows, leading to the evaluation of almost overall physiologic consequences of the macro- and microvascular impairment involved in diabetic patients. This review will provide an overview of the role of MPI in the diagnosis and risk assessment of patients with diabetes and suspected or known CAD.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Acampa W, Assante R, Zampella E, et al. Myocardial perfusion imaging for diabetes: Key points from the evidence and clinical questions to be answered. J Nucl Cardiol. 2019. PMID: 31410733. doi:10.1007/s12350-019-01846-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。